Back to Search
Start Over
An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies
- Source :
- Clinical and Translational Medicine, Vol 11, Iss 11, Pp n/a-n/a (2021)
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
- Subjects :
- Medicine (General)
R5-920
Subjects
Details
- Language :
- English
- ISSN :
- 20011326
- Volume :
- 11
- Issue :
- 11
- Database :
- Directory of Open Access Journals
- Journal :
- Clinical and Translational Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.99b1b5618214a2193bedd33dab46b7d
- Document Type :
- article
- Full Text :
- https://doi.org/10.1002/ctm2.572